In esophageal adenocarcinoma cells, CA3 – a novel inhibitor of YAP/TEAD-dependent transcription – successfully reduced tumor cell growth together with established chemotherapy (Song et al., 2018). This evidence concerns the gene YAP1 and neoplasm.